Neurotoxicologists study the effects of toxic substances on the nervous system, investigating how environmental and chemical exposures lead to neurological damage. They focus on identifying neurotoxic agents, such as heavy metals, pesticides, and industrial chemicals, that may contribute to conditions like neuropathy, cognitive impairment, and neurodegenerative diseases. Through experimental and epidemiological studies, neurotoxicologists assess the mechanisms by which these substances interfere with brain function, often leading to long-term neurological consequences. Their work also explores the genetic and environmental factors that may increase susceptibility to neurotoxicity, providing a deeper understanding of vulnerability. Neurotoxicologists collaborate with regulatory agencies to establish safety standards for chemical exposures, influencing policies that protect public health. Their research is instrumental in developing preventive strategies, mitigating the effects of neurotoxic substances, and advancing clinical approaches for individuals already exposed to these risks. Additionally, they explore the cumulative effects of long-term exposure to low levels of neurotoxic substances, assessing the potential for chronic neurological conditions. Neurotoxicologists are essential in developing public health guidelines that reduce the risk of neurotoxic harm in both occupational and environmental settings.
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States